These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 2772285)

  • 41. Pathophysiology of cyclosporine-induced nephrotoxicity in humans: a role for nitric oxide?
    Gossmann J; Radounikli A; Bernemann A; Schellinski O; Raab HP; Bickeböller R; Scheuermann EH
    Kidney Blood Press Res; 2001; 24(2):111-5. PubMed ID: 11435743
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of tezosentan, a dual endothelin receptor antagonist, on the cardiovascular and renal systems of neonatal piglets.
    Chin A; Radhakrishnan J; Fornell L; John E
    J Pediatr Surg; 2001 Dec; 36(12):1824-8. PubMed ID: 11733915
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Chronic type IV phosphodiesterase inhibition protects glomerular filtration rate and renal and mesenteric blood flow in a zymosan-induced model of multiple organ dysfunction syndrome treated with norepinephrine.
    Thomas NJ; Carcillo JA; Herzer WA; Mi Z; Jackson EK
    J Pharmacol Exp Ther; 2001 Jan; 296(1):168-74. PubMed ID: 11123377
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Arginine feeding modifies cyclosporine nephrotoxicity in rats.
    De Nicola L; Thomson SC; Wead LM; Brown MR; Gabbai FB
    J Clin Invest; 1993 Oct; 92(4):1859-65. PubMed ID: 8408638
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cholesterol feeding does not alter renal hemodynamic response to acetylcholine and angiotensin II in rabbits.
    Carroll JF; Mizelle HL; Cockrell K; Reckelhoff JF; Clower BR; Granger JP
    Am J Physiol; 1997 Mar; 272(3 Pt 2):R940-7. PubMed ID: 9087658
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Limited capacity for renal vasodilatation in anesthetized diabetic rats.
    Ha H; Dunham EW
    Am J Physiol; 1987 Oct; 253(4 Pt 2):H845-55. PubMed ID: 3661732
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of intrarenal infusion of angiotensin-(1-7) in the dog.
    Heller J; Kramer HJ; Malý J; Cervenka L; Horácek V
    Kidney Blood Press Res; 2000; 23(2):89-94. PubMed ID: 10765110
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The acute effect of FK506 and cyclosporine on endothelial cell function and renal vascular resistance.
    Benigni A; Morigi M; Perico N; Zoja C; Amuchastegui CS; Piccinelli A; Donadelli R; Remuzzi G
    Transplantation; 1992 Nov; 54(5):775-80. PubMed ID: 1279848
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of cyclosporin A on renal function and kidney growth in the uninephrectomized rat.
    Batlle DC; Gutterman C; Keilani T; Peces R; LaPointe M
    Kidney Int; 1990 Jan; 37(1):21-8. PubMed ID: 2299805
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cyclosporine and the ischemic rat kidney.
    Jablonski P; Harrison C; Howden B; Rae D; Tavanlis G; Marshall VC; Tange JD
    Transplantation; 1986 Feb; 41(2):147-51. PubMed ID: 3946011
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Lipid peroxidation accompanies cyclosporine nephrotoxicity: effects of vitamin E.
    Wang C; Salahudeen AK
    Kidney Int; 1995 Mar; 47(3):927-34. PubMed ID: 7752594
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Role of Mas receptor in renal blood flow response to angiotensin (1-7) in male and female rats.
    Nematbakhsh M; Safari T
    Gen Physiol Biophys; 2014; 33(3):365-72. PubMed ID: 24968411
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hepatic and renal blood flow responses to a clinical dose of intravenous cyclosporine in the pig.
    Andreoni KA; O'Donnell CP; Burdick JF; Robotham JL
    Immunopharmacology; 1994; 28(2):87-94. PubMed ID: 8002291
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Escherichia coli bacteremia exacerbates cyclosporine-induced renal vasoconstriction.
    Bloom IT; Bentley FR; Garrison RN
    J Surg Res; 1993 May; 54(5):510-6. PubMed ID: 8361177
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Control of renal function during intrarenal infusion of endothelin.
    Stacy DL; Scott JW; Granger JP
    Am J Physiol; 1990 May; 258(5 Pt 2):F1232-6. PubMed ID: 2186632
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Fructose-1,6-diphosphate: potential protection in cyclosporine-induced renal impairment.
    Cardoso LR; Santos OF; Boim MA; Barros EG; Ajzen H; Schor N
    Nephron; 1996; 72(1):67-71. PubMed ID: 8903863
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Chronic injury of human renal microvessels with low-dose cyclosporine therapy.
    Myers BD; Newton L; Boshkos C; Macoviak JA; Frist WH; Derby GC; Perlroth MG; Sibley RK
    Transplantation; 1988 Nov; 46(5):694-703. PubMed ID: 3057692
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cyclosporine nephrotoxicity: sodium excretion, autoregulation, and angiotensin II.
    Kaskel FJ; Devarajan P; Arbeit LA; Partin JS; Moore LC
    Am J Physiol; 1987 Apr; 252(4 Pt 2):F733-42. PubMed ID: 3551631
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Renal vasodilation induced by hypernatraemia: role of alpha-adrenoceptors in the median preoptic nucleus.
    Pedrino GR; Monaco LR; Cravo SL
    Clin Exp Pharmacol Physiol; 2009 Dec; 36(12):e83-9. PubMed ID: 19719753
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Chronic cyclosporin A nephrotoxicity, P-glycoprotein overexpression, and relationships with intrarenal angiotensin II deposits.
    del Moral RG; Andujar M; Ramírez C; Gómez-Morales M; Masseroli M; Aguilar M; Olmo A; Arrebola F; Guillén M; García-Chicano MJ; Nogales FF; O'Valle F
    Am J Pathol; 1997 Dec; 151(6):1705-14. PubMed ID: 9403721
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.